PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Aitken Scientific Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aitken Scientific Ltd Announces Advanced Statistical Process Analysis 'Skyline' - Skyline provides web access to statistical data from across lines, sites and products, allowing essential quality and production monitoring. Companies in validated environments such as the biotech and pharmaceutical industries
Aitken Scientific Ltd Announces Advanced Statistical Process Analysis 'Skyline'

 

NewswireToday - /newswire/ - Thame, Oxfordshire, United Kingdom, 2008/04/22 - Skyline provides web access to statistical data from across lines, sites and products, allowing essential quality and production monitoring. Companies in validated environments such as the biotech and pharmaceutical industries.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aitken Scientific Ltd, a leader in process control and automation, has recently become the European reseller of Comply’s process monitoring solution, Skyline. Skyline is widely applicable to anyone who needs to ensure the quality of their manufacturing processes, and the Statistical Process Control (SPC) information it provides will be of value in particular to customers focussed on GxP environments, such as the biotech and pharmaceutical industries.

Skyline offers web-based access to collate and analyse process data from many different sources across a manufacturing process. Statistical information and performance warnings can be derived from multiple machines, systems and environmental parameters, even across sites.

Skyline’s extensive reporting capabilities, including process trends, stability and Certificate Of Analysis, and management overview allow traceable record keeping and provide an overarching view of the manufacturing process beyond the capabilities of a LIMS system. Data from other controls systems, such as MES or PAT, can also be included to further enhance the monitoring detail.

James Stirling, Business Development Manager at Aitken Scientific Ltd, stated: “Skyline is an ideal compliment to our existing services and products, and we’re pleased that Aitken Scientific can extend new solutions to our customer base of biotech and pharmaceutical companies.”

Comply, based in Israel, have developed and supplied Skyline to a number of blue chip companies, including Teva and Merck, as well as a number of smaller biotech companies. Gai Anbar, CEO of Comply, says about the new agreement; “We are excited about working with Aitken Scientific to deliver Skyline to a wider audience.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Aitken Scientific Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Aitken Scientific Ltd Announces Advanced Statistical Process Analysis 'Skyline'

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: James Stirling - Aitken-Sci.com 
+44(0)18 4421 4773 pr[.]aitken-sci.co.uk
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Aitken Scientific Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Aitken Scientific Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)